▼ 2.10%
prev close
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Congressional Trades
6
All tracked trades
Members Trading
5
Unique members
Net Activity
-2
2 buys · 4 sells
Members Who Traded This Stock
6 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-01-26 | DXCMDexCom, Inc. | Buy | $1,001 - $15,000 | 157d ago | — | |
| 2025-05-12 | DXCMDexCom, Inc. | Sell | $15,001 - $50,000 | 395d ago | — | |
| 2025-04-07 | DXCMDexCom, Inc. | Sell | $15,001 - $50,000 | 440d ago | — | |
| 2025-02-25 | DXCMDexCom, Inc. | Buy | $1,001 - $15,000 | 482d ago | — | |
| 2024-12-31 | DXCMDexCom, Inc. | Sell | $50,001 - $100,000 | 553d ago | — | |
| 2022-09-28 | DXCMDexCom, Inc. | Sell | $1,001 - $15,000 | 1375d ago | — |
2026-01-26
John Boozman
DXCM
Amount
$1,001 - $15,000
Filed
157d ago
2025-05-12
Jefferson Shreve
DXCM
Amount
$15,001 - $50,000
Filed
395d ago
2025-04-07
Jefferson Shreve
DXCM
Amount
$15,001 - $50,000
Filed
440d ago
2025-02-25
Rob Bresnahan
DXCM
Amount
$1,001 - $15,000
Filed
482d ago
2024-12-31
Kevin Hern
DXCM
Amount
$50,001 - $100,000
Filed
553d ago
2022-09-28
Josh Gottheimer
DXCM
Amount
$1,001 - $15,000
Filed
1375d ago
Recent News
Powered by Polygon.io
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound
Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor
[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - Report by Zion Market Research (ZMR)
Diabetes Tech Player DexCom Lays Out 2030 Growth Vision
Trade Timeline
Congressional activity, newest first
John Boozman
2026-01-26 · Purchase
$1,001 - $15,000
Jefferson Shreve
2025-05-12 · Sale
$15,001 - $50,000
Jefferson Shreve
2025-04-07 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-02-25 · Purchase
$1,001 - $15,000
Kevin Hern
2024-12-31 · Sale
$50,001 - $100,000
Josh Gottheimer
2022-09-28 · Sale
$1,001 - $15,000